NCT06358118 - Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

July 6, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions

Diabete MellitusAgingMetabolic DisordersTraditional Chinese MedicineRandomized Controlled Trial

Interventions

DRUG

Buyuan Zhixiao Formula

DRUG

Placebo

The placebo contains 10% of the active ingredients of the Chinese medicine group

Trial Locations (6)

China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijin

Cangzhou integrative medicine hospital, Hebei

Hohhot Mongolian Traditional Chinese Medicine Hospital, Neimeng

Binzhou Traditional Chinese Medicine Hospital, Shandong

Yantai Baishi Traditional Chinese Medicine Hospital, Shandong

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

All Listed Sponsors

lead

Qing Ni

OTHER